References
- Frank W, Rohit P, Julie VS, et al. Hepatitis B in pregnancy: a concise review of neonatal vertical transmission and antiviral prophylaxis. Ann Hepatol. 2014;2:187–196.
- Tan ZM, Yin YZ, Zhou J, et al. Telbivudine treatment of hepatitis B virus-infected pregnant women at different gestational stages for the prevention of mother-to-child transmission: outcomes of telbivudine treatment during pregnancy. Medicine (Baltimore). 2016;95(40):1–8. doi:10.1097/MD.0000000000004847
- Song YM, Sung J, Yang S, Choe YH, Chang YS, Park WS. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr. 2007;166(8):813–818. doi:10.1007/s00431-006-0327-5
- Ma L, Alla NR, Li XM, et al. Mother-to-child transmission of HBV: review of current clinical management and prevention strategies. Rev Med Virol. 2014;24(6):396–406. doi:10.1002/rmv.1801
- Stanaway JD, Flaxman AD, Naghavi M, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 2016;388(10049):1081–1088. doi:10.1016/S0140-6736(16)30579-7
- Sun WH, Zhao SF, Zhao B, et al. Strategies to prevent mother to-child transmission of hepatitis B. World Chin J Digestol. 2016.
- Chinese Medical Association Society of Infectious Diseases, Chinese Grade Center. Chinese practice guideline for the prevention and treatment of hepatitis B virus mother-to-child transmission. Chinese Journal of Clinical Infectious Diseases. 2019;37(7):388–396.
- Pan CQ, Duan Z, Dai E, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med. 2016;374(24):2324–2334. doi:10.1056/NEJMoa1508660
- Zhang W, Chi PP, Wang FZ, et al. Association of maternal antiviral drugs in addition to standard care for prevention of vertical transmission of hepatitis B virus to infants born to mothers with high hepatitis B virus loads. Chin J Vaccines Immun. 2020;3:14.
- Cui F, Woodring J, Chan P, et al. Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China. Int J Epidemiol. 2018;47(5):1529–1537. doi:10.1093/ije/dyy077
- Tram T. Management of hepatitis B in pregnancy: weighing the options. Clin J Med. 2009;76(Suppl 3):S25–S29.
- Song L, Hou YP. Analysis of the correlation between the content of HBV-DNA in breast milk and the concentration of HBsAg in serum of 110 pregnant women. Exp Lab Med. 2015;6:771–773. [in Chinese].
- Chen DX. Analysis of the correlation between the level of HBV-DNA in milk and HBV-DNA in serum of 120 hepatitis B virus carriers. J Aerosp Med. 2015;26(11):1368–1369. [in Chinese].
- Huang YT, Mao ZY. Study on the safety of breast-feeding in pregnant women with positive HBV-DNA in serum. J Qiqihar Univ Med. 2014;35(14):2096–2097. [in Chinese].
- Wang Z, Han H. Clinical study on different feeding modes of HBsAg-positive women and mother-to-child transmission. Guide China Med. 2019;17(12):158–159. [in Chinese].
- Li L. Interpretation of clinical guidelines for the prevention of mother-to-child transmission of hepatitis B virus (1st edition). Chin J Obstet Gynecol Pediatr (Electron Ed). 2014;10(2):136–140. [in Chinese].
- Rui-Juan H, Kai-Xian H, Su-Qing Z. Safety of breast-feeding by hepatitis B-positive mothers. Chin Gen Pract. 2011;14:3349–3351.
- Pan CQ, Duan ZP, Bhamidimarri KR, et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol. 2012;10(5):452–459. doi:10.1016/j.cgh.2011.10.041
- Park JS, Pan CQ. Viral factors for HBV mother-to-child transmission. Hepatol Int. 2017;11(6):476–480. doi:10.1007/s12072-017-9825-y